The chemical substance with the name "4'-(2-Butyl-4-oxo-1,3-diazaspiro[4.4]-1-nonen-3-ylmethyl)-N-(3,4-dimethylisoxazol-5-yl)-2'-(3,3-dimethyl-2-oxopyrrolidin-1-ylmethyl)biphenyl-2-sulfonamide" and CAS number 254737-87-6 is a complex organic compound characterized by its multi-functional structure. It features a biphenyl core substituted with a sulfonamide group, which is known for its potential biological activity, particularly in medicinal chemistry. The presence of various heterocycles, such as isoxazole and pyrrolidine, suggests potential interactions with biological targets, making it of interest in drug development. The compound's spiro structure contributes to its three-dimensional conformation, which can influence its pharmacological properties. Additionally, the presence of alkyl groups, such as butyl and dimethyl, may enhance lipophilicity, affecting its solubility and permeability. Overall, this compound exemplifies the complexity often found in pharmaceutical agents, combining multiple functional groups that can interact with biological systems in diverse ways.

4'-(2-Butyl-4-oxo-1,3-diazaspiro[4.4]-1-nonen-3-ylmethyl)-N-(3,4-dimethylisoxazol-5-yl)-2'-(3,3-dimethyl-2-oxopyrrolidin-1-ylmethyl)biphenyl-2-sulfonamide

254737-87-6: The chemical substance with the name "4'-(2-Butyl-4-oxo-1,3-diazaspiro[4.4]-1-nonen-3-ylmethyl)-N-(3,4-dimethylisoxazol-5-yl)-2'-(3,3-dimethyl-2-oxopyrrolidin-1-ylmethyl)biphenyl-2-sulfonamide" and CAS number 254737-87-6 is a complex organic compound characterized by its multi-functional structure. It features a biphenyl core substituted with a sulfonamide group, which is known for its potential biological activity, particularly in medicinal chemistry. The presence of various heterocycles, such as isoxazole and pyrrolidine, suggests potential interactions with biological targets, making it of interest in drug development. The compound's spiro structure contributes to its three-dimensional conformation, which can influence its pharmacological properties. Additionally, the presence of alkyl groups, such as butyl and dimethyl, may enhance lipophilicity, affecting its solubility and permeability. Overall, this compound exemplifies the complexity often found in pharmaceutical agents, combining multiple functional groups that can interact with biological systems in diverse ways.

BMS-248360: Oral dual hAT1/hETA antagonist with Kis of 10nM & 1.9nM, respectively; treats hypertension.

CAS 254737-87-6

4'-(2-Butyl-4-oxo-1,3-diazaspiro[4.4]-1-nonen-3-ylmethyl)-N-(3,4-dimethylisoxazol-5-yl)-2'-(3,3-dimethyl-2-oxopyrrolidin-1-ylmethyl)biphenyl-2-sulfonamide

BMS-248360

Ref: TM-T14672